Before a hearing to determine whether the diabetes drug Avandia should stay on the market, the Institute of Medicine tells FDA to look at the safety data it already has.
Read More...
Read the complete post at http://www.npr.org/blogs/health/2010/07/09/128412235/report-says-fda-should-review-existing-drug-safety-data?ft=1&f=103537970
Posted
Jul 09 2010, 11:46 AM
by
NPR Blogs: Shots - Health News Blog